340B Covered Entities Explained: The Six Hospital Categories and Who Else Qualifies

In 1992, Congress passed Section 340B of the Public Health Service Act with a deceptively simple goal: to help safety-net healthcare providers stretch limited resources further. By requiring pharmaceutical manufacturers to offer front-end discounts on covered outpatient drugs, the program created a mechanism for eligible organizations to purchase medications at significantly reduced prices and reinvest those savings into broader patient services.

Today, the 340B Drug Pricing Program is one of the most consequential federal healthcare initiatives. Discounted drug purchases through the program reached $66.3 billion in 2023 alone, reflecting both the program’s scale and its central importance to the organizations that depend on it. But behind that headline number is a foundational question that every participating organization must answer correctly: Are we a 340B covered entity, and are we operating as one?

This is not a trivial distinction. The 340B covered entity list is not a broad invitation; it is a defined set of categories with specific eligibility requirements attached to each. Understanding where your organization fits, what criteria apply, and what that means for your day-to-day operations is the foundation of every compliant, effective 340B program. It is also where a pharmacy partner like DosePacker can make an immediate difference, not by replacing your compliance team, but by building the operational infrastructure that makes compliance manageable at scale.

DosePacker’s 340B Contract Pharmacy Solutions

What Is a 340B Covered Entity?

A 340B covered entity is a healthcare organization that meets the federal eligibility criteria established under Section 340B(a)(4) of the Public Health Service Act and is registered with the Health Resources and Services Administration (HRSA) through its Office of Pharmacy Affairs (OPA).

Once registered and approved, covered entities can purchase covered outpatient drugs at discounted prices, typically 20% to 50% below retail and wholesale rates. These discounted prices apply regardless of the patient’s payer status, meaning 340B drugs can be dispensed to eligible patients whether they are insured, on Medicaid, or uninsured.

The purpose is to enable covered entities to “stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services.” In practice, that means the savings generated through 340B participation are expected to flow back into the organization’s mission, expanded services, broader patient access, and deeper care for vulnerable populations.

What a 340B covered entity is not: an open category. The statute defines eligibility precisely, and organizations that do not meet the specific criteria for their claimed category or that fail to recertify annually are not entitled to 340B pricing regardless of the services they provide.

How the 340B Covered Entity List Is Structured

The 340B covered entity list maintained by HRSA divides eligible organizations into two broad groups: hospital-based covered entities and non-hospital covered entities.

The hospital-based group is defined by statute as six specific categories. Each hospital type has distinct eligibility criteria, and most must meet payer-mix thresholds tied to the Medicare Disproportionate Share Hospital (DSH) program, as well as ownership or operational requirements related to government affiliation or nonprofit status serving low-income populations.

The non-hospital group includes federally funded providers that qualify based on participation in specific government grant programs rather than hospital-specific metrics. These organizations tend to be community-based health centers, disease-specific clinics, and grantee programs serving concentrated underserved populations.

Understanding this two-part structure matters because compliance obligations, contract pharmacy rules, patient eligibility standards, and audit exposure can vary by category a covered entity falls under. Treating all 340B covered entities as interchangeable is one of the most common and most consequential misunderstandings in 340B program management. DosePacker’s 340B contract pharmacy services are built with this category-specific nuance in mind, offering distinct operational frameworks for hospital-based entities and non-hospital covered entities alike.

The Six Categories of 340B Eligible Hospitals

According to HRSA and confirmed by 340B Health’s program overview, the statute identifies six hospital categories as eligible 340B covered entities. Each carries its own eligibility pathway.

1. Disproportionate Share Hospitals (DSH)

Disproportionate Share Hospitals are acute care hospitals that serve a disproportionately high share of low-income patients. To qualify as a 340B-covered entity in this category, a hospital must have a Medicare DSH adjustment percentage above 11.75%, a metric calculated as the proportion of the hospital’s patient population covered by Medicaid or receiving Supplemental Security Income.

DSH hospitals are typically the largest and most prominent participants in the 340B program. They treat high volumes of uninsured and Medicaid patients and operate under significant financial pressure, making the drug cost savings generated through 340B particularly impactful. In addition to the DSH adjustment threshold, qualifying hospitals must be owned or operated by state or local government, formally granted governmental powers, or be a private nonprofit under contract with a state or local government to provide care to low-income individuals not eligible for Medicaid or Medicare.

DosePacker’s centralized portal and audit-ready documentation practices are designed specifically to help high-volume DSH participants maintain program integrity across large patient populations and multiple dispensing points.

2. Children’s Hospitals

Children’s hospitals that are exempt from the Medicare prospective payment system qualify as 340B covered entities under a separate pathway from DSH hospitals. Because they serve a pediatric patient population and operate outside the standard Medicare payment structure, the DSH adjustment percentage threshold does not apply to them in the same way.

These hospitals must still meet the governmental-ownership or nonprofit-status criteria that apply across all hospital categories. Their eligibility reflects the distinct financial reality of hospitals that provide specialized, often complex, care to a patient population that skews heavily toward Medicaid and uninsured coverage.

The medication regimens managed in pediatric settings can be particularly sensitive, with weight-based dosing, specialty formulations, and complex care plans common.

3. Freestanding Cancer Hospitals

These are also exempt from the Medicare prospective payment system in a specific, relatively small category within the 340B-covered entity list. Like children’s hospitals, they are exempt from the DSH adjustment percentage requirement but must satisfy the governmental or nonprofit affiliation criteria.

These facilities tend to treat complex oncology cases and manage high-cost specialty drug regimens, making the savings available through 340B especially significant. Their inclusion in the program reflects congressional recognition of the financial burden of cancer care and the importance of ensuring that safety-net cancer centers can maintain access to treatment for underserved patients.

DosePacker’s secure document management and OPAIS registration support help freestanding cancer hospitals build and maintain the audit trail that high-value drug programs demand.

4. Critical Access Hospitals (CAH)

They are rural hospitals designated by their state and certified by CMS to provide essential healthcare services to geographically isolated communities. CAH status requires, among other things, that a facility have no more than 25 inpatient beds, maintain an average length of stay of no more than 96 hours for acute care patients, and be located more than 35 miles from another hospital (or 15 miles in areas with mountainous terrain or secondary roads).

Notably, CAH are the only hospital category under 340B that is not required to meet the payer-mix criteria linked to the Medicare DSH program. Their eligibility is based on geographic necessity and the essential role they play in rural healthcare infrastructure.

5. Rural Referral Centers (RRC)

Rural Referral Centers are larger rural hospitals that serve as regional referral destinations, drawing patients from surrounding communities for more complex care than smaller rural facilities can provide. To qualify as a 340B covered entity in this category, a hospital must meet CMS criteria for RRC designation, including volume thresholds, service complexity measures, and geographic requirements, and must also satisfy the DSH adjustment percentage threshold and the governmental or nonprofit criteria.

RRCs occupy a distinct space in rural healthcare: they are not the small critical access facilities that serve the most isolated populations, but they are also not urban academic medical centers. They absorb referrals from a wide rural catchment area and often operate under margin pressures, making 340B savings materially important to their financial sustainability.

6. Sole Community Hospitals (SCH)

Sole Community Hospitals are the only acute care hospitals within a defined geographic area. CMS designates SCH status based on distance from other hospitals and the hospital’s role as the sole source of inpatient care for the surrounding community. Like DSH hospitals, Sole Community Hospitals must meet the payer-mix threshold and ownership criteria to qualify as 340B covered entities.

The rationale for including SCHs in the 340B program is straightforward: in communities without an alternative hospital, the financial health of the sole community hospital is inseparable from healthcare access for the entire population. The 340B program provides a structural mechanism to help these hospitals manage the cost of caring for patients who cannot pay, without compromising their ability to remain the community’s only source of inpatient care.

DosePacker’s compliance-first contract pharmacy approach, with its structured contracting process and centralized documentation, gives Sole Community Hospitals the same level of program oversight that larger urban systems enjoy with far greater internal resources.

Non-Hospital 340B Covered Entities

Beyond the six hospital categories, HRSA recognizes a range of non-hospital organizations as eligible 340B covered entities. These organizations qualify based on federal funding and programmatic criteria rather than hospital-specific metrics, and they represent a significant portion of the overall 340B covered entity list.

Federally Qualified Health Centers (FQHCs) are community health center program award recipients that receive federal grants under Section 330 of the Public Health Service Act. They serve as primary care hubs for medically underserved communities and are among the most active non-hospital participants in the 340B program.

FQHC Look-Alikes are health centers that meet all the programmatic requirements of FQHCs but do not receive Section 330 grant funding. They are recognized by HRSA as meeting FQHC standards and are eligible for 340B participation on that basis.

Native Hawaiian Health Centers and Tribal and Urban Indian Health Centers serve distinct federally recognized patient populations and qualify through their connection to Indian Health Service programs or Native Hawaiian health funding.

Ryan White HIV/AIDS Program Grantees, including clinics, programs, and state-operated AIDS Drug Assistance Programs, qualify through their participation in the Ryan White CARE Act, which funds care for people living with HIV/AIDS. Given the high cost of antiretroviral therapies and related medications, 340B pricing is particularly impactful for these programs. Medication adherence is also a critical clinical priority for Ryan White grantees, an area where DosePacker’s medication management solutions provide tangible support alongside 340B savings.

Specialized Clinics, including Title X family planning clinics, sexually transmitted disease clinics, tuberculosis clinics, black lung clinics, and comprehensive hemophilia diagnostic treatment centers, round out the non-hospital side of the 340B covered entity list. Each qualifies through its connection to specific federal grant or program funding and serves a concentrated population with specific healthcare needs.

Why Category Matters for Compliance, Not Just Eligibility

Understanding which category of the 340B covered entity list an organization falls under is not merely an administrative formality. Category determines the specific compliance obligations, contract pharmacy rules, patient definition standards, and audit risk profile that apply to the organization’s 340B program.

Staying Current on the 340B Covered Entity List

HRSA maintains a publicly accessible 340B covered entity list through its 340B OPAIS (Office of Pharmacy Affairs Information System). This database includes all currently registered and eligible covered entities, their designated pharmacy locations, and relevant eligibility information.

All 340B covered entities are required to recertify their eligibility annually. Recertification requires the organization’s authorizing official to attest to 340B compliance, including compliance at any contract pharmacy locations. HRSA also requires covered entities to notify OPA immediately when any change in eligibility occurs, such as a shift in DSH adjustment percentage or a change in government funding status, and to stop purchasing drugs through the program as of the date eligibility is lost.

DosePacker’s OPAIS registration assistance ensures that covered entities, whether newly registering or adding contract pharmacy locations, complete the process accurately and on time. The typical contracting process takes two to four weeks, depending on documentation and OPAIS processing timelines, and DosePacker’s team manages every step, from initial review to final documentation, within a centralized, audit-ready portal.

How DosePacker Supports 340B Covered Entities

Understanding eligibility is the first step. Operating a compliant, savings-maximizing 340B program on an ongoing basis is where the real work begins and where the right pharmacy partner makes a measurable difference.

DosePacker’s 340B contract pharmacy services are designed to help covered entities of all types build 340B programs that generate real savings while maintaining the documentation, tracking, and workflow standards required by HRSA compliance. Whether your organization is a DSH navigating complex payer-mix calculations or an FQHC managing prescription access for high-volume, underserved patient populations, DosePacker provides operational infrastructure that aligns with the requirements for your specific category of covered entity.

Here is what that looks like in practice:

Complete transparency and centralized access. All contracts, communications, and documents are accessible through a centralized portal, ensuring that every contract pharmacy relationship is documented, trackable, and audit-ready from day one.

Consistent contracting and OPAIS support. DosePacker guides covered entities through the full OPAIS registration and agreement process, reducing administrative burden and minimizing the risk of data errors that can delay or jeopardize registration.

Ongoing monitoring and dedicated support. A single point of contact manages every stage of the contracting lifecycle, from initial setup to ongoing compliance documentation, so your team does not navigate HRSA requirements alone.

That operational alignment matters because the gap between what the 340B statute permits and what an organization actually captures in savings is almost always a process problem, not an eligibility problem. Covered entities leave savings on the table and expose themselves to audit risk when their medication management workflows, documentation practices, and contract pharmacy arrangements are not built to the standard their category requires. DosePacker closes that gap.

Learn how our contract pharmacy services can strengthen your organization’s 340B program.

Contact DosePacker today

Frequently Asked Questions

1. What is the difference between a 340B covered entity and a contract pharmacy?

A 340B covered entity is the eligible healthcare organization that purchases drugs at discounted 340B prices and is registered with HRSA. A contract pharmacy is an outside pharmacy that a covered entity may designate to dispense those 340B-purchased drugs to eligible patients on the covered entity’s behalf. The covered entity remains legally responsible for compliance, including patient eligibility determinations and the prevention of duplicate discounts and diversion. Contract pharmacies are service agents, not covered entities themselves.

2. Can a healthcare organization be on the 340B covered entity list in more than one category?

In most cases, a facility registers under a single category that reflects its primary eligibility. However, some organizations that operate multiple distinct sites or program types may have different locations registered under different categories if each independently meets the criteria for its respective category. This is particularly relevant for health systems that operate both DSH hospitals and FQHC-designated clinic locations. Each registration is assessed separately by HRSA, and compliance obligations apply independently to each.

3. What happens if a covered entity’s eligibility status changes mid-year?

If a covered entity experiences a change that affects its eligibility, for example, a hospital whose DSH adjustment percentage drops below the required threshold during a recertification review, the organization must immediately notify HRSA through 340B OPAIS and stop purchasing drugs through the program as of the effective date of the change. Continuing to purchase at 340B prices after losing eligibility is a program violation and may result in repayment obligations, interest penalties, or disqualification from future participation.